SymBiosis Capital Partners, LLC
CIK
2006045
Location
BENTONVILLE, AR
Portfolio Value
Micro
$52,768,253
Diversification
Highly concentrated
Filing Date
Global Rank
#8,441
/ 8,807
▼ 628
· as of Mar 2026
Top Industry
Biotechnology
96.0%
3Y Alpha vs SPY
-97.8%
Period ended 6 months ago
Filed May 12, 2026 · 5mo
2 quarters · since Dec 2025
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
6 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
55.8%
+33.9 pts
Top 5
100.0%
+26.9 pts
Top 10
100.0%
0.0 pts
HHI
3,875
Highly concentrated+2,540
Portfolio Trend
2 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 96.0% | $50,642,960 |
| Consumer Defensive | 4.0% | $2,125,293 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
New Positions
Positions the filer opened this quarter
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| WVE | Wave Life Sciences, Inc. | 750,000 | $5,437,500 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
6 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| VSTM | Verastem, Inc. | 2,000,000 | $15,440,000 | |
| PGEN | Precigen, Inc. | 3,000,000 | $12,540,000 | |
| NUVB | Nuvation Bio Inc. | 1,250,000 | $11,200,000 | |
| AMPG | AmpliTech Group, Inc. | 2,555,000 | $7,639,450 | |
| AARD | Aardvark Therapeutics, Inc. | 476,595 | $6,255,309 | |
| — | 665,000 | $0 | ||
| No positions match the current search. | ||||
6 tracked positions ·
$52,768,253 total
· filing declares
6 positions · $52,769,920
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| EVMN |
Evommune, Inc.
Healthcare
|
Held | 1,280,778 | $29,445,086 | 55.80% | |
| IVA |
Inventiva S.A.
Healthcare
|
Reduced | 2,354,000 | $13,064,700 | 24.76% | |
| WVE |
Wave Life Sciences, Inc.
Healthcare
|
NEW | 750,000 | $5,437,500 | 10.30% | |
| RANI |
Rani Therapeutics Holdings, Inc.
Healthcare
|
Reduced | 3,667,585 | $2,695,674 | 5.11% | |
| CLNN |
Clene Inc.
Consumer Defensive
|
Reduced | 431,094 | $2,125,293 | 4.03% | |
| SRZN |
Surrozen, Inc./DE
Healthcare
|
Held | 150,000 | $0 | 0.00% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.